| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
76,114 |
64,870 |
$16.81M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64,820 |
49,737 |
$853K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,448 |
4,719 |
$116K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,152 |
8,467 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,494 |
12,718 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
584 |
431 |
$3K |
| 93000 |
|
871 |
683 |
$924.43 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,826 |
4,836 |
$564.39 |
| 81000 |
|
14,761 |
11,850 |
$520.28 |
| 3008F |
|
21,126 |
17,214 |
$262.53 |
| 3080F |
|
1,414 |
1,284 |
$262.53 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,623 |
1,508 |
$168.81 |
| 81025 |
|
3,540 |
3,132 |
$162.43 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,036 |
873 |
$104.67 |
| 94664 |
|
91 |
82 |
$93.22 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
553 |
476 |
$85.21 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,154 |
1,766 |
$34.58 |
| 85018 |
|
586 |
504 |
$5.35 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,587 |
3,928 |
$5.30 |
| 82962 |
|
998 |
792 |
$4.05 |
| 3079F |
|
4,289 |
3,815 |
$0.00 |
| 3075F |
|
2,498 |
2,185 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,131 |
1,108 |
$0.00 |
| 3074F |
|
9,893 |
8,420 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
205 |
203 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
60 |
60 |
$0.00 |
| 86580 |
|
20 |
12 |
$0.00 |
| 90656 |
|
17 |
17 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
21 |
21 |
$0.00 |
| 99441 |
|
172 |
165 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
25 |
15 |
$0.00 |
| 3078F |
|
8,951 |
7,591 |
$0.00 |
| 3077F |
|
1,166 |
921 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,463 |
2,668 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,379 |
2,535 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
272 |
268 |
$0.00 |
| 1159F |
|
751 |
384 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
183 |
154 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
70 |
47 |
$0.00 |
| 99442 |
|
26 |
25 |
$0.00 |
| 1160F |
|
739 |
377 |
$0.00 |
| 69209 |
|
20 |
18 |
$0.00 |